Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 887.97K | $ 1.25M | $ 3.01M | $ 3.96M | $ 1.52M |
Total Assets | $ 6.06M | $ 7.67M | $ 7.86M | $ 6.52M | $ 3.69M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 206.68K | $ 137.80K | $ 202.71K | $ 79.84K | $ 121.62K |
Stockholders Equity | $ 5.85M | $ 7.54M | $ 7.66M | $ 6.44M | $ 3.56M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |